Craft Beer, COVID, and Distilleries

August 11, 2020
150320221647327583

PRI brings together distillery owners, craft brewers, and licensing experts to examine the impact that COVID-19 has had on the production of our favorite cocktails and beers.

 

Tuesday, August 11, 2020
11am Pacific Time

 

Panel:

Jarrett Dieterle, Director of Commercial Freedom and Senior Fellow, R Street Institute
Cris Steller, Dry Diggings Distillery, El Dorado Hills, CA
Daniel Moffatt Co-Owner and Head Brewer, Fountainhead Brewing Company, Sacramento, CA
 

The coronavirus pandemic continues to wreak havoc on the American economy. The craft beer and distillery industry is one that has seen incredible disruption, with states and counties opening and closing breweries almost overnight. California, like many other states, has adjusted its alcohol distribution and regulations to allow breweries and distilleries easier access to customers. Are these regulations working? Are there any changes needed? What does the rest of 2020 look like?  Should temporary regulatory relief be made permanent?
 

We will discuss these topics and more with a distillery owner, craft brewer, and subject matter expert on federal alcohol regulations. You’ll hear how breweries and distilleries are adapting and surviving in one of the most trying economic times in modern history straight from the source (or tap).

We will also talk about how regulatory changes have helped or hurt distilleries and breweries, and what steps can be taken to ensure the industry survives the uncertainty of the coronavirus pandemic.


(function(d, s) {
var js, el = d.getElementsByTagName(s)[0];
window.BB_REG_FORM_ID = “71f98626-06b4-4fc4-a77f-269104ac0b84”;
window.BB_REG_FORM_ENVIRONMENT_ID = “p-VFwaa-F3ZU6uSLzlD1sBnw”;
js = d.createElement(s);
js.src = “https://sky.blackbaudcdn.net/skyuxapps/registration-form/assets/online_registrations_form_loader_v1.f8744b9a2e1826070a839886cbb55c9de563274d.js”;
el.parentNode.insertBefore(js, el);
})(document, “script”);

Tell Your Friends

Related

Modern,Medical,Research,Laboratory,With,Microscope,And,Test,Tubes,With

Trump Embraces Disastrous Most Favored Nation Drug Pricing

President Donald Trump gave American drug companies an ultimatum last month. Either they agree to adopt foreign-style price controls, or the administration “will deploy every ...
business econ title

Using The Government To Crush Competitors Harms Fans And The Economy

Cronyism and industrial policy are thriving to the detriment of our economic vibrancy. Consider that between 1960 and 2007 – right before the Great Recession ...
MoneyMapPharmacy

Tariffs Won’t Secure Our Drug Supply Chain—They’ll Break It

The Trump administration is considering massive “Section 232” tariffs on imported medicines from key U.S. allies, including the European Union, the United Kingdom, Switzerland, Japan, ...
Scroll to Top